Description

The global pharmaceutical contract manufacturing & research services market is set to grow by US$ 50 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period, according to data and analytics company StrategyHelix. Increasing R&D investment, favorable government intervention, increase in pharmaceutical outsourcing practices are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for pharmaceutical contract manufacturing & research services. The global pharmaceutical contract manufacturing & research services market is segmented on the basis of service type, applications, region. By service type, it is categorized into manufacturing, packaging, and research. The manufacturing segment held the largest market share in 2020. However, the research segment is expected to witness the highest CAGR during the forecast period. By applications, the pharmaceutical contract manufacturing & research services market is divided into cardiovascular, oncology, antibiotics, analgesics, antivirals, and others. Based on region, the pharmaceutical contract manufacturing & research services market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as AbbVie Inc., Amcor Ltd., AMRI (Albany Molecular Research Inc.), Delpharm SAS, Eurofins Scientific SE, Fareva Group, Lonza Group AG, Patheon N.V., Pfizer CentreOne, Recipharm AB, Siegfried AG.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pharmaceutical contract manufacturing & research services market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Service type: manufacturing, packaging, and research
Applications: cardiovascular, oncology, antibiotics, analgesics, antivirals, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the global pharmaceutical contract manufacturing & research services market
Pinpoint growth sectors and trends for investment
Understand what the future of the global pharmaceutical contract manufacturing & research services market looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Pharmaceutical Contract Manufacturing & Research Services Market by Service Type
4.1 Manufacturing
4.2 Packaging
4.3 Research
5. Pharmaceutical Contract Manufacturing & Research Services Market by Applications
5.1 Cardiovascular
5.2 Oncology
5.3 Antibiotics
5.4 Analgesics
5.5 Antivirals
5.6 Others
6. Pharmaceutical Contract Manufacturing & Research Services Market by Region
6.1 North America
6.2 Asia Pacific
6.3 Europe
6.4 Rest Of The World (Row)
7. Company Profiles
7.1 AbbVie Inc.
7.2 Amcor Ltd.
7.3 AMRI (Albany Molecular Research Inc.)
7.4 Delpharm SAS
7.5 Eurofins Scientific SE
7.6 Fareva Group
7.7 Lonza Group AG
7.8 Patheon N.V.
7.9 Pfizer CentreOne
7.10 Recipharm AB
7.11 Siegfried AG
8. Appendix
8.1 About StrategyHelix
8.2 Disclaimer